- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 16.51M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 16.74M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 17.01M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $12.28M |
| Capex | Q1 2026 · Mar 31, 2025 | $9.12M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $4.4M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$3.55M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $1.95M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $2.65M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.12B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $1.11B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $1.02B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $997.39M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $8.49B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $8.39B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $9.61B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $9.5B |
| Total Assets restated | Q1 2026 · Mar 31, 2025 | $9.08B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $1.99 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $1.52 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $2.00 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $1.53 |
| Net Income | Q1 2026 · Mar 31, 2026 | $33.38M |
| Net Income | Q1 2026 · Mar 31, 2025 | $25.8M |